Neoadjuvant Carboplatin/Paclitaxel versus 5-Fluorouracil/Cisplatin in Combination with Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Comparative Study

SIMPLE SUMMARY: The most beneficial neoadjuvant chemoradiotherapy for Asian patients with esophageal squamous cell carcinoma remains uncertain. Using propensity score matching by inverse probability of treatment weighting to balance the baseline variables, the neoadjuvant carboplatin/paclitaxel (CRO...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xing, Tsai, Ping-Chung, Chuang, Kai-Hao, Pai, Chu-Pin, Hsu, Po-Kuei, Li, Shau-Hsuan, Lu, Hung-I, van Lanschot, Joseph Jan-Baptist, Chao, Yin-Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179264/
https://www.ncbi.nlm.nih.gov/pubmed/35681592
http://dx.doi.org/10.3390/cancers14112610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179264/
https://www.ncbi.nlm.nih.gov/pubmed/35681592
http://dx.doi.org/10.3390/cancers14112610

Ejemplares similares